Anne has 25 years investing and mentoring experience with MedStars, and has been a pioneer entrepreneur and investor in the emerging HealthTech sector. Companies in which Anne has been involved have been market changers and have grown to $6 billion market cap. She has startup operating experience as CEO and VP as well as public and private board positions. Anne earned a Master in Business Engineering, Brussels and an MBA, Harvard.
Glen Tullman is Chairman and Chief Executive Officer of Livongo Health™. Tullman is also a successful entrepreneur and co-founder and Managing Partner of 7wire Ventures, a Chicago-based investment firm focused on healthcare and education. Tullman most recently served as Chief Executive Officer of Allscripts (NASDAQ: MDRX), the leading global provider of Electronic Health Records, Practice Management and Electronic Prescribing systems. He led Allscripts’ IPO and secondary offerings. Under his leadership, revenues grew from $30 million in 1997 to more than $1.4 billion in 2012. Tullman stepped down in December 2012.
Prior to joining Allscripts, Tullman was CEO of Enterprise Systems, a leading healthcare-information services company providing resource-management solutions to large, integrated healthcare networks. Tullman led its IPO and secondary offerings. Enterprise was sold to McKesson HBOC (NYSE: MCK).
Jeff Margolis is widely recognized as a healthcare IT entrepreneur and innovator based on his 30-year track record of successfully applying technologies to address the complex problems facing the healthcare industry. Leveraging his deep systematic understanding of healthcare and groundbreaking architectural and integration methodologies, Jeff has built some of the nation’s largest and most innovative healthcare technology and service organizations.
Jeff is currently Chairman and CEO of Welltok, Inc., where he is driving the transformation of our current sickcare system to one of optimized health. Prior to Welltok, Jeff founded TriZetto, the first industry vertical SaaS enterprise solution, and originated the concept of Integrated Healthcare Management. During his tenure as Chairman and CEO, Jeff led TriZetto through a successful IPO and $1.4B private equity buyout.
Amir Dan Rubin serves as President and CEO of Stanford Health Care, which seeks to serve humanity through science and compassion, one patient at a time, through its commitment to care, educate, and discover. With an operating budget of $2.7 Billion and an affiliation with Stanford University, Stanford Health Care provides leading edge and coordinated care across its growing healthcare system.Read full bio →
Rich Roth leads Dignity Health's innovation efforts, which seek to create and test novel services, programs, partnerships, and/or technologies – from within and outside of healthcare – that challenge the status quo and have the potential to reduce the cost of care, improve quality, and/or increase access to services. Working in concert with Dignity Health employees and physicians, Roth works to anticipate emerging trends and technologies with the goal of incubating, studying, and scaling efforts to improve care. Dignity Health's current focus is in the areas of mobile care and sensor based technology. Roth holds a Master's degree in Healthcare Administration from the University of Minnesota and a Bachelors degree in Public Health from West Chester University. He regularly advises venture capital organizations, and is on the Board of Ascension Health Ventures. In 2012, he was recognized by CHAUSA as one of the most promising leaders under 40 in healthcare.
Tom is responsible for identifying and fostering innovative ideas that enhance the growth of NSLIJ’s clinical and non-clinical enterprises, working with senior leadership to develop and advance ideas in these areas, bringing these ideas into practice and the market, as well as building strategic partnerships and relationships within the broader regional ecosystem and beyond. In this role, he manages all the North Shore-LIJ’s innovation programs; including technology commercialization, enterprise growth and investment management.
Prior to joining North Shore-LIJ, Tom led the Healthcare Innovation Alliance at Cleveland Clinic Innovations; a program aimed at forming multi-institutional collaborations to foster and accelerate the commercialization of medical innovations.
Dr. Molly Joel Coye is Social Entrepreneur in Residence for the Network for Excellence in Health Innovation (NEHI), a nonprofit national health policy institute focused on enabling innovations that provide solutions to the most pressing issues facing our health care system today. From 2010 – 2015, Dr. Coye was the Chief Innovation Officer for UCLA Health and headed the Institute for Innovation in Health and the Global Lab for Innovation at UCLA, where she led the health system in identifying new strategies, technologies, products and services to support the large-scale transformation of healthcare. Today the Global Lab for Innovation advances the exchange of health delivery innovations that enable dramatic improvements in access to and affordability of health services. Dr. Coye also advises technology developers, investors, national health systems and policy makers about disruptive technologies and business models that accelerate transformation and constrain health expenditures.Read full bio →
Dr. Rhee serves as Chief Health Officer and Vice President of IBM, where he has direct global responsibilities for all IBM integrated health services strategy, design and operations, which include key support and leadership of business development and corporate citizenship opportunities in health and healthcare. Prior to joining IBM, Dr. Rhee was Chief Public Health Officer at the Health Resources and Services Administration (HRSA), which is the primary federal agency for improving access to health care services for people who are uninsured, isolated, or medically vulnerable. While at HRSA, he served on and led numerous national initiatives related to prevention, quality, and public health. Dr. Rhee also served as the Director of the Office of Innovation and Program Coordination at the National Institutes of Health (NIH), which is the primary federal agency for research. While at NIH, he served on and led numerous initiatives related to eliminating health disparities and promoting health equity.Read full bio →
For 20 years, Derek has been leading innovative health technology and service companies. He led the company that built the first FDA-approved internet connected medical device and grew it into the world’s largest remote patient monitoring company. Before that, at LifeMasters, he helped pioneer the first patient-centric disease management platform and built one of the largest disease management companies in the US. Derek holds graduate degrees in business and public health from UC Berkeley.
Dr. Rusty Hofmann, from Stanford Health, co-founded Grand Rounds with the goal of ensuring access to state-of-the-art care to everyone, everywhere. A few years ago, his son, Grady, became extremely ill and almost died. Dr. Hofmann was able to get an expert opinion from the country’s leading pediatric gastroenterologists on Grady’s diagnosis and treatment, which ultimately saved his life. With his “insider status,” Dr. Hofmann had access to the world’s greatest medical minds. Founded in 2011, Grand Rounds was born out of Dr. Hofmann’s vision to make all health care consumers “medical insiders.” The Grand Rounds solution helps restore individual health and quality of life, and benefits employers by facilitating decreased health care cost and increased employee productivity.Read full bio →
Dr. Hariprasad currently leads the strategy and development of Ginger.io’s clinical programs, applying the advanced technology platform to the frontlines of clinical deployment. He is an experienced psychiatrist and innovator with background in the practice of medicine, engineering and clinical research. Prior to joining Ginger.io, he served as a clinical leader at Kaiser Permanente and launched two successful companies in mobile technology and data security software. Dr. Hariprasad received his M.D. from the University of Pennsylvania and his B.S. in Operations Research Engineering from Cornell University. He completed both his residency training and received his M.P.H from Harvard University (Massachusetts General Hospital). Dr. Hariprasad has also complemented his formal training with studies in the traditional sciences of Vedic wellness and Ayurvedic medicine.
Eve is the CEO & Co-Founder of Empower Interactive, Inc., a leader in digital behavioral health solutions. She is an experienced Silicon Valley product builder, entrepreneur and investor with expertise in assembling diverse teams to solve hard problems. Eve started her career as a product manager at Trilogy, an enterprise e-commerce software company, working on new ventures. From there, Eve held product, strategy and business development roles in software and internet businesses including Microsoft, Zazzle and eCert. Eve has also been a member of the investment teams at Amadeus Capital Partners, Vector Capital, and Greylock Partners. Prior to co-founding Empower, Eve was a Research Affiliate in the Synthetic Neurobiology Group at the MIT Media Lab. Eve holds an MBA from Stanford University and an SB and an M.Eng in Computer Science from the Massachusetts Institute of Technology.
Seth Feuerstein is a psychiatrist, entrepreneur and technology executive responsible for driving technology innovation within Magellan’s computerized cognitive behavioral therapy platform and programs. This portfolio is the leading behavioral change and engagement software suite used by millions of individuals throughout the U.S., U.K. and other health systems. Awarded the TripleTree iAward for Connected Health in the area of “Clinical Effectiveness,” this software was developed by Feuerstein’s team at Cobalt Therapeutics, a company he started and where he served as CEO until the company was acquired by Magellan in 2014.Read full bio →
Alon Matas founded BetterHelp, the world's largest e-counseling platform. With BetterHelp, anyone facing life's challenges can have an easy, affordable, and private access to a licensed and certified therapist. BetterHelp's members get professional counseling using their computer, tablet or mobile phone, anytime they need, anywhere they are. In 2015 BetterHelp was acquired by Teladoc (NYSE: TDOC), the nation's first and largest telehealth provider.
Prior to BetterHelp, Alon was the Founder and CEO of three startups in the consumer web space, leading them through their entire life cycles: conceptualizing, planning, fundraising, team building, product design, development, launch, iteration, commercialization, optimization, growth, and eventually M&A.
Alon is an advocate, advisor and mentor for ventures and ideas that use tech-based innovations to improve quality of life.
David Sayen assumed the position of Regional Administrator of the Centers for Medicare & Medicaid Services, Region IX in February 2008. David is based in San Francisco, and his jurisdiction includes California, Arizona, Nevada, Hawaii, and the Pacific Territories. He replaces Acting Regional Administrator Charlotte Yeh, who is returning to her regular duties as Regional Administrator of the New England region of CMS.Read full bio →
Dr. Rideout was recently appointed as President and CEO of the Integrated Healthcare Association. The Integrated Healthcare Association is a California statewide multi-stakeholder leadership group that promotes quality improvement, accountability and affordability of health care. Dr. Rideout also serves as a Senior Advisor to GE Ventures, focusing on new business development related to Digital Health and Digital Therapeutics, including assessing and accelerating new early stage solutions and companies. Dr. Rideout holds academic appointments with Stanford University and University of California Berkeley Haas School of Business, teaching on topics related to healthcare technology, services and investment.Read full bio →
Sam Glick is a Partner in Oliver Wyman’s Health and Life Sciences practice, and the San Francisco Office Leader. He focuses on consumer-centric healthcare, working with leading providers, health plans, employers, enablement companies, retailers, and venture capital firms to find innovative, engaging ways to bend trend. He is an author of several recent Oliver Wyman points of view, including A Billion-Dollar Decision: Charting a New Course for US Healthcare Benefits and Private Exchanges Change the Game. Sam also leads many of Oliver Wyman’s healthcare commercialization research and intellectual capital development efforts.Read full bio →
Chris has devoted his career to converting deep consumer insights into commercial value. He began his career in product management at Johnson & Johnson, where he rose quickly to run the $1B TYLENOL franchise, before starting his own marketing services business in 1998, called Rosetta. Chris and his team built Rosetta over the subsequent 13 years to be the largest privately held digital marketing agency in the world, before they sold it to the Publicis Groupe for a record price in 2011.Read full bio →
Dr. Levy brings more than 30 years of senior operational leadership and experience in the medical device industry. Prior to Chrono Therapeutics, he was the founding CEO of Incline Therapeutics that was acquired by The Medicines Company in January 2013 for up to $390 million.Read full bio →
Mike is a commercial leader who has worked with companies in almost every sector of health care. He believes that small companies with new ideas can change healthcare, but only if they work hand-in-hand with current leaders in the healthcare world. He is committed to making Omada into the leader of a new generation of health providers focused on evidence-based digital health programs for specific, complex diseases. Mike joined Omada from biotechnology leader Gilead Sciences, where he spent 6 years as Senior Director of Commercial Strategy, with experience in new product development, M&A, and marketing. Mike was previously with the healthcare practice at McKinsey & Company where he worked with healthcare clients in biotechnology/pharma, medical devices, health systems, and global health. Mike has an MBA from Stanford Business School as well as an MSc in Health Services Research from Stanford Medical School.
Rick Altinger serves as Glooko’s first CEO, and brings over 15 years of industry experience in healthcare information technologies. While an executive at Intuit Health, Altinger helped launch the healthcare division’s provider services and drove Intuit’s acquisition of Medfusion in 2010. He also spearheaded Intuit Health’s growth as the leading supplier of patient-provider communication and patient portal services. His technical knowledge and expertise is central to Glooko’s diabetes healthcare platform and its goal of allowing anyone to monitor blood glucose levels regardless of meter, pump, CGM or mobile device type.
Jack heads up the Qualcomm Life Fund (QLF) at Qualcomm Ventures, which was ranked as one of the most active venture investors in digital health. He is also a fund manager at dRx Capital, a Novartis and Qualcomm joint investment company. His investment interests are focused on the intersection of healthcare products and services and digital/wireless technologies. Jack’s current digital health investments include: Airstrip, AliveCor, ClearCare, Doctor On Demand, goBalto, Telcare and Welltok. Prior investments include: Validity (acquired by Synaptics), and Fitbit (NYSE: FIT).Read full bio →
Renee Compton Ryan, Vice President, Venture Investments, joined Johnson & Johnson Innovation - JJDC, Inc. (JJDC) in 2011. She is based in Silicon Valley, California. Mrs. Ryan's background includes over 20 years of healthcare investment banking. Most recently, she ran the medical device investment banking effort at R.W. Baird & Co.
Previously, she lead the West Coast medical device group at Jefferies & Co. and was in the healthcare investment banking groups at Goldman Sachs and Credit Suisse. Mrs. Ryan received an MBA from Columbia Business School and a Bachelors degree from Georgetown University.
With over 30 years of experience, Casper is a veteran of the medical device and life sciences industry. He brings extensive operating knowledge to Norwest Venture Partners having led marketing and commercialization efforts for cardiovascular device, specialty pharmaceutical, and diagnostic companies. Casper focuses on mid-to-late-stage investments in medical devices, specialty pharmaceuticals, healthcare services, and healthcare IT. Along with his current board seats at Intersect ENT, iRhythm Technologies, and Simpirica Spine, Casper has invested in Misfit Wearables. He was previously on the board of Basis (acquired by Intel).
Tom Rodgers is the Senior Vice President and Managing Director leading McKesson Ventures. He spent more than a decade in health care venture capital, most recently leading strategic investing efforts for Cambia Health, and before that as a Partner with Advanced Technology Ventures.Read full bio →
October 27, 2015
Gale Richards has built and developed senior leadership teams for fast-growing Healthcare Technology companies for over 25 years. As both a seasoned executive recruiter and a hands-on sales and marketing leader in the healthcare space, Gale knows what it takes to understand a company’s DNA and build the right teams to accomplish its mission.
As a partner at BioQuest since 2003, Gale has become an essential advisor to CEOs, board members and venture capitalists as they search for exactly the right talent for their senior leadership teams. Gale’s search experience is international and includes C-suite, board members and senior executives for every cross-functional role. Gale’s sectors of expertise include: Digital Health, Medical Devices and Diagnostics.
Michael O'Donnell is a partner in the Palo Alto office of Morrison & Foerster LLP, specializing in corporate and securities law. He has more than 30 years of experience providing general corporate representation to biopharmaceutical and other life sciences companies. He offers particular expertise in venture capital financings, public offerings, mergers and acquisitions, strategic alliances, technology licensing, and corporate spin-out transactions. He represents numerous public and private biopharmaceutical, medical device, diagnostic, and instrumentation companies.
Robin Cisneros provides strategic direction and oversight of Kaiser Permanente’s new medical product and technology assessment and selection processes. For more than 25 years, Robin has been developing and leading the organization’s evidence-based, physician-led resources that assess, select, and purchase medical products and technology. This includes directing a complex, national network of clinical and business leaders, serving on several national KP initiatives, while aligning resources and clinical leadership to support large scale projects that deliver increasing value to patients and KP.
Healthcare investor Wende Hutton brings 20 years of experience to identifying, investing in and building companies that are changing the practice of medicine. She has facilitated bringing over a dozen medical devices and drugs to market, and currently sits on the boards of Aldea Pharmaceuticals, Butterfly Health, Chimerix (CMRX), Dermira, Labrys Biologics, ReVision Optics, Theraclone Sciences and Transcend Medical.Read full bio →
Noah Lewis specializes in MedTech and SaaS investing—with a focus on disease management business models integrating smart devices, software analytics and services. He founded GE Ventures portfolio operating practice and dedicates much of his time growing his previous investments including board positions at Ornim Medical, Veran Medical and Acutus Medical. Noah was named a "Top 10 Healthcare VC on Twitter", is quoted by industry journals including Medical Device & Diagnostics Industry and MedCityNews and is a frequent expert speaker at investment and globalization forums including the MedTech Investing Conference, the China, India & U.S. Life Science Markets Summit and the Private Equity & Venture Capital Summit. Prior to entering Venture Capital, he led strategic planning for the $10B GE Healthcare Systems division and started his career in the technology industry at IBM. Noah holds an MBA degree from MIT and a BS degree from Skidmore College. Noah lives in San Francisco and goes cycling in the Marin countryside any chance he gets.
Joel Krikston is a Managing Director with Merck’s Global Health Innovation Fund, LLC (“GHI”). Joel is focused on identifying new investment opportunities in Health Information Technology and Technology Enabled Solutions with an emphasis on Decision Support, Accountable Care and Population Health. Joel is currently on the Board of MedCPU, Inc., is a Board Observer at Electrocore, LLC and is GHI’s representative to the New York Digital Health Accelerator.Read full bio →
Seth oversees Evolent Health’s client transformation practice. He most recently served as the Chief Transformation Officer for the Geisinger Health System prior to joining Evolent. His responsibilities included providing business leadership to large-scale innovation projects within the health system (e.g., Geisinger Accelerated Performance Program) and external consulting for Geisinger Ventures. Prior to Geisinger, Seth was Senior Vice President, Strategic Services for The Children’s Hospital of Philadelphia (CHOP). Seth led CHOP’s proton therapy development initiative, national contracting for tertiary services and strategic plan development and management. Before assuming the strategic services role, Seth had executive responsibilities for CHOP-affiliated Children’s Health Net, a pediatric managed care organization that developed and managed a globally capitated 100+ PCP network under contract with the dominant regional HMO. Seth came to CHOP after a 9-year consulting career with a large national health care firm. His practice areas included clinical resource management, managed care, service line strategy, hospital redesign and strategy.